Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 90 (ZNF90) is a predicted DNA-binding transcription factor, acting at RNA polymerase II cis-regulatory regions to regulate gene expression. While it is a member of the large zinc finger protein family involved in diverse nuclear processes, ZNF90 itself is not established as a therapeutic target nor directly linked to human disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 90 (ZNF90).